Team G Childhood Cancer Foundation is honored and privileged to introduce the first Pediatric Oncologist for our Medical Advisory Board. Dr. Doug Hawkins was introduced via email to founders Adam and Kristin during their daughter, Gabriella’s cancer treatments. Since Dr. Hawkins is the chair of the sarcoma committee for the Children’s Oncology Group, the doctors at Lucile Packard Children’s Hospital would often refer questions to our “out of state” oncologist. Kristin and Adam had the opportunity to recently meet Dr. Hawkins at Seattle Children’s Hospital and tour the research centers. To say we are ecstatic that Dr. Hawkins is the first member of our Medical Advisory Board would be an understatement. With guidance and direction in funding pediatric cancer from this knowledgeable physician, Team G will make great progress. Read more about Dr. Doug Hawkins HERE.
Douglas S. Hawkins, MD, is Associate Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Childrens Hospital (SCH), clinician at SCH, and professor at the University of Washington School of Medicine. Hawkins is the principal investigator for COG activity at SCH and chair of the COG Soft Tissue Sarcoma Committee.
He is a steering committee member of several COG committees, including the Soft Tissue Sarcoma, Bone Tumor, and Voting Body. He is also the Chair of the COG Scientific and Discipline Chairs Committee. Dr. Hawkins has focused on clinical research, particularly in the treatment of pediatric sarcomas. He is the COG chair of two clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma. He is collaborating on a pharmacogenomic study investigating cyclophosphamide metabolism and toxicity, both locally and as part of two COG studies. In addition, he collaborates on the use of FDG PET to assess response and guide treatment in pediatric sarcomas.
-
TITLE
- Associate Division Chief, Hematology/Oncology, Seattle Children’s
- Professor of Pediatrics, University of Washington School of Medicine
Board Certification(s)
- Pediatric Hematology-Oncology
- Medical/Professional School
- Harvard Medical School, Boston
- Residency
- Pediatrics, University of Washington, Seattle
- Research Description
- My clinical research is particularly focused in the treatment of pediatric sarcomas. I am the Children’s Oncology Group (COG) chair of the Soft Tissue Sarcoma Committee, which designs and conducts all national studies in pediatric soft tissue sarcomas, including rhabdomyosarcoma. I am the COG chair of two clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma, and the vice chair of three other COG clinical trials. I am working collaboratively on a pharmacogenomic study investigating cyclophospharmide metabolism and toxicity, both locally and as part of two COG studies, and on the use of FDG PET to assess response and guide treatment in pediatric sarcomas.